Brief: Rallybio Reports Q1 2023 Financial Results
May 9 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* AS OF MARCH 31, 2023, CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES WERE $150.4 MILLION
* $150.4 MILLION CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
AS OF MARCH 31, 2023; PROVIDES RUNWAY INTO 1Q 2025
* Q1 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw32MvbWa
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx